Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$40.45
-2.32%
Mkt Cap $1.44B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (13 analysts)
$72.20
Range $63.00 – $94.00
Implied Upside
+78.5%
Consensus $72.20 vs current $40.45